EXOCRINE PANCREATIC INSUFFICIENCY

This study looked at whether children with cystic fibrosis (CF) who are taking CFTR modulator drugs and have regained normal pancreatic function can safely stop taking pancreatic enzyme replacement therapy (PERT). Seventeen children were followed for six months after stopping enz…

This early-stage study tested a new medicine called ANG003 in 57 adults with cystic fibrosis who have trouble digesting food due to a lack of digestive enzymes. Participants took a single dose of the drug with a meal to see if it was safe and helped with digestion. The goal was t…

This study creates a registry of adults with pancreatic exocrine insufficiency (PEI), a condition where the pancreas does not produce enough enzymes to digest food properly. Researchers at eight specialist centers across Europe will track how doctors prescribe pancreatic enzyme r…

This completed study created a registry of 400 adults with exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis. Researchers collected real-world data on disease history, treatment patterns, and quality of life through patient reports and clinic visits. The goal…